Current lab members
Andrew Deans (Unit head)
Andrew studied for his PhD at the Peter MacCallum Cancer Institute, where he developed an interest in how the cell cycle and DNA repair are involved in the development of breast cancer. In 2006, he moved to the UK to work with Steve West at the London Research Institute (now the Francis Crick Institute). In 2012, he returned to Australia to head the Genome Stability Unit at St Vincent's Institute. He is an expert on the genetic disorder Fanconi Anaemia, as well as familial breast cancer predisposition - both of which are associated with deficiencies in the repair of DNA damage. His leadership in the field of Fanconi anaemia research was recognised in 2017 as recipient of the David B Frohnmayer award.
Andrew studied for his PhD at the Peter MacCallum Cancer Institute, where he developed an interest in how the cell cycle and DNA repair are involved in the development of breast cancer. In 2006, he moved to the UK to work with Steve West at the London Research Institute (now the Francis Crick Institute). In 2012, he returned to Australia to head the Genome Stability Unit at St Vincent's Institute. He is an expert on the genetic disorder Fanconi Anaemia, as well as familial breast cancer predisposition - both of which are associated with deficiencies in the repair of DNA damage. His leadership in the field of Fanconi anaemia research was recognised in 2017 as recipient of the David B Frohnmayer award.
Wayne Crismani (lab head)
Wayne joined the lab in April 2016 after previously working at INRA (France) and then DuPont Pioneer, on the role of Fanconi anaemia proteins in plant meiosis. He is working on finding new modulators of DNA repair processes in humans, that have implications for cancer initiation and chemotherapy treatment.
Wayne joined the lab in April 2016 after previously working at INRA (France) and then DuPont Pioneer, on the role of Fanconi anaemia proteins in plant meiosis. He is working on finding new modulators of DNA repair processes in humans, that have implications for cancer initiation and chemotherapy treatment.
Michael Sharp (Postdoctoral scientist)
Michael joined the lab in March 2017 after completing a PhD in immunology at James Cook University. He is expanding our work on the role of Fanconi Anaemia proteins and their regulators in response to chemotherapy.
Michael joined the lab in March 2017 after completing a PhD in immunology at James Cook University. He is expanding our work on the role of Fanconi Anaemia proteins and their regulators in response to chemotherapy.
Elyse Dunn (Postdoctoral scientist)
Elyse joined the lab in July 2017. Her previous experience in the disparate fields of structural biology and human disease epidemiology will be combined, to help us understand how variation in FANCC and FANCM genes contribute to familial breast cancer predisposition.
Elyse joined the lab in July 2017. Her previous experience in the disparate fields of structural biology and human disease epidemiology will be combined, to help us understand how variation in FANCC and FANCM genes contribute to familial breast cancer predisposition.
Rohan Bythell-Douglas (Postdoctoral scientist)
Michael joined the lab in January 2018 after completing a postdoc with Dale Wigley at Imperial College London. Michael is investigating the structure and function of various proteins in the Fanconi anaemia pathway.
Michael joined the lab in January 2018 after completing a postdoc with Dale Wigley at Imperial College London. Michael is investigating the structure and function of various proteins in the Fanconi anaemia pathway.
Vincent Murphy (Research assistant)
Vince is an experienced biochemist who has made a career of protein production at the Ludwig Institute, WEHI, LaTrobe University, AdAlta and now the Genome Stability lab at SVI. He works to purify and crystallise several proteins that are important in maintaining genome stability and suppressing cancer.
Vince is an experienced biochemist who has made a career of protein production at the Ludwig Institute, WEHI, LaTrobe University, AdAlta and now the Genome Stability lab at SVI. He works to purify and crystallise several proteins that are important in maintaining genome stability and suppressing cancer.
Sylvie van Twest (Research assistant)
Sylvie has been in the lab from the beginning! Hailing from Canada, Sylvie has a Masters degree in Cellular and Molecular Biology from the University of Guelph, Ontario. Sylvie is working on biochemical reconstitution of the Fanconi Anaemia DNA repair pathway, and its role in the cancer predisposition syndrome Fanconi Anaemia.
Sylvie has been in the lab from the beginning! Hailing from Canada, Sylvie has a Masters degree in Cellular and Molecular Biology from the University of Guelph, Ontario. Sylvie is working on biochemical reconstitution of the Fanconi Anaemia DNA repair pathway, and its role in the cancer predisposition syndrome Fanconi Anaemia.
Winnie Tan (PhD student)
Winnie undertook honours in the lab in 2015 and has returned in 2016 to work on understanding the important role that ubiquitination plays in DNA damage response.
Winnie undertook honours in the lab in 2015 and has returned in 2016 to work on understanding the important role that ubiquitination plays in DNA damage response.
Vanessa Tsui (PhD student)
Vanessa has a Masters degree from University of Melbourne. She joined the lab in 2018, to study the role of various DNA proteins in meiosis, the immune system and during gene editing.
Vanessa has a Masters degree from University of Melbourne. She joined the lab in 2018, to study the role of various DNA proteins in meiosis, the immune system and during gene editing.
Astrid Glaser (Postdoctoral scientist)
Your name here?
The genome stability lab is always on the look out for enthusiastic and adventurous honours and PhD students or postdocs. Informal applications are accepted by emailing Andrew Deans.
The genome stability lab is always on the look out for enthusiastic and adventurous honours and PhD students or postdocs. Informal applications are accepted by emailing Andrew Deans.
Alumni
Charlotte Hodson (Postdoctoral scientist)
Charlotte completed a PhD at the London Research Institute, where she solved the structure and mechanism of the FANCL ubiquitin ligase, defective in Fanconi anaemia. She started in the lab in 2014, and worked on mechanisms that control the fidelity of homologous recombination repair, and R-loop metabolism - of great importance in suppression of cancer mutations. She returned to the UK in 2017 to continue her structural biology work at Astex Pharmaceuticals.
Charlotte completed a PhD at the London Research Institute, where she solved the structure and mechanism of the FANCL ubiquitin ligase, defective in Fanconi anaemia. She started in the lab in 2014, and worked on mechanisms that control the fidelity of homologous recombination repair, and R-loop metabolism - of great importance in suppression of cancer mutations. She returned to the UK in 2017 to continue her structural biology work at Astex Pharmaceuticals.
Eiffel Tolentino (Honours student)
Eiffel is completing is Bachelor of Biomedical Science at the Australian Catholic University. In 2018 he will work closely with Elyse to investigate variants in DNA repair genes linked to familial breast cancer. His project specifically examines a set of rare FANCM variants that cluster only in women with a family history breast cancer.
Eiffel is completing is Bachelor of Biomedical Science at the Australian Catholic University. In 2018 he will work closely with Elyse to investigate variants in DNA repair genes linked to familial breast cancer. His project specifically examines a set of rare FANCM variants that cluster only in women with a family history breast cancer.
Julienne O'Rourke (PhD student)
Julienne undertook honours in the lab in 2013 and completed an outstanding thesis : "Inhibition of the Bloom's Syndrome Pathways as a Mechanism of Chemotherapy". Julienne has been awarded a PhD scholarship from the Leukaemia Foundation to continue this project in the lab.
Julienne undertook honours in the lab in 2013 and completed an outstanding thesis : "Inhibition of the Bloom's Syndrome Pathways as a Mechanism of Chemotherapy". Julienne has been awarded a PhD scholarship from the Leukaemia Foundation to continue this project in the lab.
Leon Burgdorf (Visiting Masters Student)
Leon is completing a Master of Science at ETHZ Zurich, Switzerland, with a major in biochemistry. He was at SVI, for a 6 month project in 2017-18 investigating the function of the FANCA protein in the Fanconi Anaemia DNA repair pathway.
Leon is completing a Master of Science at ETHZ Zurich, Switzerland, with a major in biochemistry. He was at SVI, for a 6 month project in 2017-18 investigating the function of the FANCA protein in the Fanconi Anaemia DNA repair pathway.
Fenil Shah (Postdoctoral scientist)
Fenil completed a PhD at Griffith University (Brisbane). He started in the lab in 2012, looking at how phosphorylation regulates DNA repair in the Fanconi anaemia DNA repair pathway.
He is now in the USA, continuing work in the DNA repair field with Mark R Kelley.
Fenil completed a PhD at Griffith University (Brisbane). He started in the lab in 2012, looking at how phosphorylation regulates DNA repair in the Fanconi anaemia DNA repair pathway.
He is now in the USA, continuing work in the DNA repair field with Mark R Kelley.
Nikolas Sie (Undergraduate student)
Nik spent 4 months with us in 2015, working on several RecQ helicases as part of an undergraduate exchange program from the University of Wuerzburg, Germany.
Nik spent 4 months with us in 2015, working on several RecQ helicases as part of an undergraduate exchange program from the University of Wuerzburg, Germany.
James Beddoes (Honours students)
James is undertaking an honours year via the University of Melbourne . His project is investigating the targeting of DNA repair pathways as a mechanism of treating familial breast cancer.
James is undertaking an honours year via the University of Melbourne . His project is investigating the targeting of DNA repair pathways as a mechanism of treating familial breast cancer.
